Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1983; 2:872-878
© 1983 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olivari, M.
Right arrow Articles by Cohn, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olivari, M.
Right arrow Articles by Cohn, J.

Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure

MT Olivari, PF Carlyle, TB Levine, and JN Cohn

The hemodynamic and hormonal responses to nitroglycerin administered transdermally in a gel-like matrix were evaluated in nine patients with severe congestive heart failure and in nine normal subjects. In normal subjects, peripheral vasodilation was accompanied by reflex sympathetic stimulation as reflected by an increase in heart rate and plasma norepinephrine. In patients with heart failure, nitroglycerin produced sustained hemodynamic effects that began 30 minutes after the application and fully persisted for at least 6 hours. A significant decrease in right and left ventricular filling pressures was associated with an increase in stroke index and a significant decrease in forearm and pulmonary vascular resistances. There was no change in heart rate and systemic arterial pressure or in plasma norepinephrine or plasma renin activity. After 24 hours, pressures had partially returned to control levels, but mean pulmonary artery pressure was still significantly lower than in the control period. After removal of the nitroglycerin, each patient exhibited a decrease in cardiac index and an increase, above the control values, in pulmonary and systemic arterial pressures and pulmonary, systemic and forearm vascular resistances. This transient rebound appeared to be unrelated to stimulation of the sympathetic or renin-angiotensin systems. Thus, transdermal absorption of this new form of nitroglycerin appears to provide a nitrate vascular effect that is sustained for 24 hours, but an endogenous vasoconstrictor effect may influence the hemodynamic response over the first 24 hours.


This article has been cited by other articles:


Home page
CirculationHome page
J. D. Parker, A. B. Parker, B. Farrell, and J. O. Parker
Intermittent Transdermal Nitroglycerin Therapy : Decreased Anginal Threshold During the Nitrate-Free Interval
Circulation, February 15, 1995; 91(4): 973 - 978.
[Abstract] [Full Text]


Home page
ANN INTERN MEDHome page
U. Elkayam
Tolerance to Organic Nitrates: Evidence, Mechanisms, Clinical Relevance, and Strategies for Prevention
Ann Intern Med, April 15, 1991; 114(8): 667 - 677.
[Abstract] [PDF]


Home page
JAMAHome page
J. Abrams
A Reappraisal of Nitrate Therapy
JAMA, January 15, 1988; 259(3): 396 - 401.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
J. ABRAMS
Transdermal Nitroglycerin and Nitrate Tolerance
Ann Intern Med, March 1, 1986; 104(3): 424 - 426.
[Abstract] [PDF]


Home page
J Biomater ApplHome page
M. Szycher
Recent Advances in Transdermal Delivery Systems
J Biomater Appl, January 1, 1986; 1(2): 207 - 238.
[PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement